The American Review of Respiratory Disease, Volume 148National Tuberculosis Association, 1993 - Respiratory organs Includes Abstracts section, previously issued separately. |
Contents
Respiratory | 805 |
CONTENTS | 833 |
Effect of Surfactant Therapy and Ventilation | 845 |
Copyright | |
33 other sections not shown
Common terms and phrases
activity acute adults aerosol aeruginosa airway alveolar amiloride analysis antibody antigen apnea Appl Physiol arterial asthma baseline beryllium biopsy blood bronchial bronchoconstriction capsaicin cells chest chlorothiazide chronic ciprofloxacin Clin clinical CO₂ concentrations COPD correlation corticosteroids CT Grade cystic fibrosis decreased dose dyspnea effect elastase eosinophil epithelial evaluation expired breath exposure factor fibrosis figure fluid groups guinea pig H₂O₂ hirudin histamine Hospital hypoxic increased infants infection inflammation infusion inhaled inhibition intravenous lavage levels lung disease measured Medical mg/kg misoprostol muscle nebulizer neopterin neutrophils normal obstructive ozone patients pediatric placebo plasma pleural pressure preterm protein pulmonary function rats receptor respiratory response Rev Respir rSLPI saline samples sarcoidosis sensitized serum significant significantly sleep SLPI SNORESAT sodium sputum subjects surfactant tachykinins tachyphylaxis theophylline therapy thrombin tion tissue tracheal sounds treatment values variability ventilation versus volume weaning µg/ml